Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

ALL

Transcription factor NF-κB is constitutively activated in acute lymphoblastic leukemia cells

Abstract

The pleiotropic transcription factor NF-κB controls cellular apoptotic and growth processes and increasing evidence suggests a role in tumorigenesis. We describe here that constitutively activated NF-κB complexes are found in the vast majority (39 out of 42 samples) of childhood acute lymphoblastic leukemia (ALL) without any subtype restriction. Electrophoretic shift analysis further demonstrates that these complexes are composed of p50-p50 and p65-p50 dimers. Proteasome inhibition in primary ALL cultures results in a hyperphosphorylated form of IκBα, indicating that activation of upstream kinases, which trigger IκBα degradation, has led to nuclear translocation of NF-κB. Careful inhibition of cellular proteolytic activities is of importance when analyzing extracts from primary ALL cells. Degradation of p65 and other proteins in ALL samples could be specifically suppressed by α-1 antitrypsin. Constitutive NF-κB activation is thus a common characteristic of childhood ALL and strongly suggests a critical role of this factor for leukemia cell survival.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Baeuerle PA, Henkel T . Function and activation of NF-κB in the immune system Annu Rev Immunol 1994 12: 141–179

    Article  CAS  PubMed  Google Scholar 

  2. Wulczyn FG, Krappmann D, Scheidereit C . The NF-κB and IκB gene families: mediators of immune response and inflammation J Mol Med 1996 74: 749–769

    Article  CAS  PubMed  Google Scholar 

  3. Attar RM, Caamano J, Carrasco D, Iotsova V, Ishikawa H, Ryseck RP, Weih F, Bravo R . Genetic approaches to study Rel/NF-κB/IκB function in mice Semin Cancer Biol 1997 8: 93–101

    Article  CAS  PubMed  Google Scholar 

  4. Luque I, Gelinas C . Rel/NF-κB and IκB factors in oncogenesis Semin Cancer Biol 1997 8: 103–111

    Article  CAS  PubMed  Google Scholar 

  5. May MJ, Ghosh S . Rel/NF-κB and IκB proteins: an overview Semin Cancer Biol 1997 8: 63–73

    Article  CAS  PubMed  Google Scholar 

  6. Kaltschmidt C, Kaltschmidt B, Neumann H, Wekerle H, Baeuerle PA . Constitutive NF-κB activity in neurons Mol Cell Biol 1994 14: 3981–3992

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Bargou RC, Emmerich F, Krappmann D, Bommert K, Mapara MY, Arnold W, Royer HD, Grinstein E, Greiner A, Scheidereit C, Dorken B . Constitutive NF-κB/RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells J Clin Invest 1997 100: 2961–2969

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Sovak MA, Bellas RE, Kim DW, Zanieski GJ, Rogers AE, Traish AM, Sonenshein GE . Aberrant NF-κB/Rel expression and the pathogenesis of breast cancer J Clin Invest 1997 100: 2952–2960

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Shattuck-Brandt RL, Richmond A . Enhanced degradation of IκBα contributes to endogenous activation of NF-κB in Hs294T melanoma cells Cancer Res 1997 57: 3032–3039

    CAS  PubMed  Google Scholar 

  10. Wang W, Abbruzzese JL, Evans DB, Larry L, Cleary KR, Chiao PJ . The nuclear factor κB RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells Clin Cancer Res 1999 5: 119–127

    CAS  PubMed  Google Scholar 

  11. Mori N, Fujii M, Ikeda S, Yamada Y, Tomonaga M, Ballard DW, Yamamoto N . Constitutive activation of NF-κB in primary adult T-cell leukemia cells Blood 1999 93: 2360–2368

    CAS  PubMed  Google Scholar 

  12. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS Jr . NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation Science 1998 281: 1680–1683

    Article  CAS  PubMed  Google Scholar 

  13. Beg AA, Baltimore D . An essential role for NF-κB in preventing TNF-α-induced cell death Science 1996 274: 782–784

    Article  CAS  PubMed  Google Scholar 

  14. Wang CY, Mayo MW, Baldwin AS Jr . TNF-and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB Science 1996 274: 784–787

    Article  CAS  PubMed  Google Scholar 

  15. Perkins ND, Felzien LK, Betts JC, Leung K, Beach DH, Nabel GJ . Regulation of NF-κB by cyclin-dependent kinases associated with the p300 coactivator Science 1997 275: 523–527

    Article  CAS  PubMed  Google Scholar 

  16. Hinz M, Krappmann D, Eichten A, Heder A, Scheidereit C, Strauss M . NF-κB function in growth control: regulation of cyclin D1 expression and G0/G1 to S phase transition Mol Cell Biol 1999 19: 2690–2698

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Krappmann D, Emmerich F, Kordes U, Scharschmidt E, Dörken B, Scheidereit C . Molecular mechanisms of constitutive NF-κB/Rel activation in Hodgkin/Reed–Sternberg cells Oncogene 1999 18: 943–953

    Article  CAS  PubMed  Google Scholar 

  18. Wood KM, Roff M, Hay RT . Defective IκBα in Hodgkin cell lines with constitutively active NF-κB Oncogene 1998 16: 2131–2139

    Article  CAS  PubMed  Google Scholar 

  19. Emmerich F, Meiser M, Hummel M, Jundt F, Mathas S, Dehmel G, Foss H-D, Krappmann D, Scheidereit C, Stein H, Dörken B . Overexpression of IκBα without inhibition of NF-κB activity and mutations in the IκBα gene in Reed–Sternberg cells Blood 1999 94: 3129–3134

    CAS  PubMed  Google Scholar 

  20. Look AT . Oncogenic transcription factors in the human acute leukemias Science 1997 278: 1059–1064

    Article  CAS  PubMed  Google Scholar 

  21. Wulczyn FG, Krappmann D, Scheidereit C . Signal-dependent degradation of IκBα is mediated by an inducible destruction box that can be transferred to NF-κB, bcl-3 or p53 Nucleic Acids Res 1998 26: 1724–1730

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Liptay S, Seriu T, Bartram CR, Schmid RM . Germline configuration of nfkb2, c-rel and bcl3 in childhood acute lymphoblastic leukemia (ALL) Leukemia 1997 11: 1364–1366

    Article  CAS  PubMed  Google Scholar 

  23. Hamdane M, David-Cordonnier MH, D'Halluin JC . Activation of p65 NF-κB protein by p210BCR-ABL in a myeloid cell line Oncogene 1997 15: 2267–2275

    Article  CAS  PubMed  Google Scholar 

  24. Reuther JY, Reuther GW, Cortez D, Pendergast AM, Baldwin AS Jr . A requirement for NF-κB activation in Bcr-Abl-mediated transformation Genes Dev 1998 12: 968–981

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank U Anderer, Charité Berlin, for pediatric tumor cell lines, R Marschalek, University Erlangen, and T Look, SJCRH, Memphis, TN, for ALL cell lines, KH Seeger, Virchow Klinikum Berlin for ALL samples, respectively, and H Riehm and M Schrappe (chairmen of the ALL-BFM study) for continuous support. R Dettmer kindly provided highly purified, bacterially expressed IκBα.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kordes, U., Krappmann, D., Heissmeyer, V. et al. Transcription factor NF-κB is constitutively activated in acute lymphoblastic leukemia cells. Leukemia 14, 399–402 (2000). https://doi.org/10.1038/sj.leu.2401705

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2401705

Keywords

This article is cited by

Search

Quick links